Local 12: Breakthrough device guides surgeons in locating breast cancer tumors

Local 12 highlighted research from the University of Cincinnati Cancer Center that found a seed device that acts as a GPS for surgeons to locate and remove breast and lymph node tumors was safe and effective. 

UC's Jaime Lewis, MD, a Cancer Center physician-researcher and associate professor of surgery in the UC College of Medicine, said use of the SmartClip devices improves efficiency since radiologists can schedule the implantation when it works best for them, and then the day of surgery is also shorter.

"They can be put in the day before surgery, they can be put in three months before surgery,” Lewis told Local 12.

Watch or read the Local 12 story.

Read more about the UC research.

Featured photo at top of the SmartClip and introducer. Photo courtesy of Elucent.

Related Stories

1

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.